Contract Manufacturing, Drug Substance, API

>

Latest News

A CDMO’s Perspective on Outsourcing Challenges for ADCs–Part 2
A CDMO’s Perspective on Outsourcing Challenges for ADCs–Part 2

February 12th 2025

Christian Morello, vice president and head of the Bioconjugates Business Unit at Lonza, looks at what is involved in developing modern ADCs.

3d rendering of Antibody drug conjugates (ADCs) are targeted medicines that deliver chemotherapy agents to cancer cells | Image Credit: © Love Employee - © Love Employee- stock.adobe.com
Advancing ADCs to the Next Level

February 4th 2025

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com
APIIC Receives $14M Award for Development, Production of Three APIs

September 13th 2024

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - stock.adobe.com
Aurigene to Provide Cell Therapy Discovery Services to Edity to Support Clinical Development

July 2nd 2024

A hand in a blue glove selects pills on a gray background. The concept of the problem of correct choice in the variety of different medicines | Image Credit: © Aleksandr - © Aleksandr - Stock.adobe.com
The New Digital Era for Formulation Development

October 16th 2023

<1
...
456